HEADER DEHYDROGENASE 16-JAN-98 1A27 TITLE HUMAN 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 1 C-TERMINAL DELETION TITLE 2 MUTANT COMPLEXED WITH ESTRADIOL AND NADP+ COMPND MOL_ID: 1; COMPND 2 MOLECULE: 17-BETA-HYDROXYSTEROID-DEHYDROGENASE; COMPND 3 CHAIN: A; COMPND 4 EC: 1.1.1.62; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL_LINE: SPODOPTERA FRUGIPERDA; SOURCE 6 CELLULAR_LOCATION: CYTOPLASM; SOURCE 7 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10469; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SPODOPTERA FRUGIPERDA; SOURCE 10 EXPRESSION_SYSTEM_CELLULAR_LOCATION: CYTOPLASM; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: VIRUS; SOURCE 12 EXPRESSION_SYSTEM_VECTOR: BACULOVIRUS; SOURCE 13 EXPRESSION_SYSTEM_PLASMID: PVL1393 KEYWDS DEHYDROGENASE, 17-BETA-HYDROXYSTEROID, MUTANT, ESTRADIOL, NADP EXPDTA X-RAY DIFFRACTION AUTHOR C.MAZZA,R.BRETON,D.HOUSSET,J.-C.FONTECILLA-CAMPS REVDAT 6 02-AUG-23 1A27 1 REMARK REVDAT 5 11-APR-18 1A27 1 REMARK REVDAT 4 04-APR-18 1A27 1 REMARK REVDAT 3 13-JUL-11 1A27 1 VERSN REVDAT 2 24-FEB-09 1A27 1 VERSN REVDAT 1 27-MAY-98 1A27 0 JRNL AUTH C.MAZZA JRNL TITL HUMAN TYPE I 17BETA-HYDROXYSTEROID DEHYDROGENASE: SITE JRNL TITL 2 DIRECTED MUTAGENESIS AND X-RAY CRYSTALLOGRAPHY JRNL TITL 3 STRUCTURE-FUNCTION ANALYSIS JRNL REF THESIS, UNIVERSITE JOSEPH 1997 JRNL REF 2 FOURIER JRNL PUBL GRENOBLE : UNIVERSITE JOSEPH FOURIER (THESIS) JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.MAZZA,R.BRETON,D.HOUSSET,J.C.FONTECILLA-CAMPS REMARK 1 TITL UNUSUAL CHARGE STABILIZATION OF NADP+ IN REMARK 1 TITL 2 17BETA-HYDROXYSTEROID DEHYDROGENASE REMARK 1 REF J.BIOL.CHEM. V. 273 8145 1998 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 2 REMARK 1 AUTH R.BRETON,D.HOUSSET,C.MAZZA,J.C.FONTECILLA-CAMPS REMARK 1 TITL THE STRUCTURE OF A COMPLEX OF HUMAN 17BETA-HYDROXYSTEROID REMARK 1 TITL 2 DEHYDROGENASE WITH ESTRADIOL AND NADP+ IDENTIFIES TWO REMARK 1 TITL 3 PRINCIPAL TARGETS FOR THE DESIGN OF INHIBITORS REMARK 1 REF STRUCTURE V. 4 905 1996 REMARK 1 REFN ISSN 0969-2126 REMARK 1 REFERENCE 3 REMARK 1 AUTH D.GHOSH,V.Z.PLETNEV,D.W.ZHU,Z.WAWRZAK,W.L.DUAX,W.PANGBORN, REMARK 1 AUTH 2 F.LABRIE,S.X.LIN REMARK 1 TITL STRUCTURE OF HUMAN ESTROGENIC 17 BETA-HYDROXYSTEROID REMARK 1 TITL 2 DEHYDROGENASE AT 2.20 A RESOLUTION REMARK 1 REF STRUCTURE V. 3 503 1995 REMARK 1 REFN ISSN 0969-2126 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 15081 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 805 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2181 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 157 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.014 ; 0.020 REMARK 3 ANGLE DISTANCE (A) : 0.030 ; 0.030 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.038 ; 0.050 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.015 ; 0.020 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.194 ; 0.200 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.459 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.309 ; 3.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.625 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.008 ; 4.000 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1A27 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000170301. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : FEB-96 REMARK 200 TEMPERATURE (KELVIN) : 130 REMARK 200 PH : 7.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9827 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ESRF REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15988 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 70.6 REMARK 200 DATA REDUNDANCY : 2.830 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03400 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 34.5 REMARK 200 DATA REDUNDANCY IN SHELL : 1.12 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.16200 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1FDT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLIZED FROM 12-16 % REMARK 280 PEG4000, 100 MM HEPES PH 7.1, 0.5 MM ESTRADIOL, 200 MM NACL, REMARK 280 100MM MGCL2, 2.2 MM DECYL-BETA-D-MALTOSIDE; THEN SOAKED IN 30 % REMARK 280 PEG 4000, 100 MM HEPES PH 7.1, 100 MM MGCL2, 0.5 MM ESTRADIOL, 1 REMARK 280 MM NADP+ REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 55.69000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.27000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 55.69000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 24.27000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 9140 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21150 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -47.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 286 REMARK 465 VAL A 287 REMARK 465 PRO A 288 REMARK 465 ALA A 289 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 VAL A 196 REMARK 475 LEU A 197 REMARK 475 GLY A 198 REMARK 475 SER A 199 REMARK 475 PRO A 200 REMARK 475 GLU A 201 REMARK 475 GLU A 202 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O VAL A 196 O HOH A 551 1.99 REMARK 500 O GLU A 202 NH1 ARG A 206 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 2 CD - NE - CZ ANGL. DEV. = 11.9 DEGREES REMARK 500 ARG A 67 CD - NE - CZ ANGL. DEV. = 11.0 DEGREES REMARK 500 ARG A 67 NE - CZ - NH1 ANGL. DEV. = 4.6 DEGREES REMARK 500 ARG A 76 CD - NE - CZ ANGL. DEV. = 11.9 DEGREES REMARK 500 ARG A 83 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ASP A 112 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 ARG A 120 NE - CZ - NH1 ANGL. DEV. = 4.2 DEGREES REMARK 500 ARG A 136 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 95 119.05 -160.01 REMARK 500 VAL A 115 -63.81 -99.44 REMARK 500 THR A 190 -2.93 -153.13 REMARK 500 LEU A 197 168.29 131.09 REMARK 500 SER A 199 65.31 89.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CAT REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CATALYTIC SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EST A 350 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 360 DBREF 1A27 A 1 289 UNP P14061 DHB1_HUMAN 1 289 SEQRES 1 A 289 ALA ARG THR VAL VAL LEU ILE THR GLY CYS SER SER GLY SEQRES 2 A 289 ILE GLY LEU HIS LEU ALA VAL ARG LEU ALA SER ASP PRO SEQRES 3 A 289 SER GLN SER PHE LYS VAL TYR ALA THR LEU ARG ASP LEU SEQRES 4 A 289 LYS THR GLN GLY ARG LEU TRP GLU ALA ALA ARG ALA LEU SEQRES 5 A 289 ALA CYS PRO PRO GLY SER LEU GLU THR LEU GLN LEU ASP SEQRES 6 A 289 VAL ARG ASP SER LYS SER VAL ALA ALA ALA ARG GLU ARG SEQRES 7 A 289 VAL THR GLU GLY ARG VAL ASP VAL LEU VAL CYS ASN ALA SEQRES 8 A 289 GLY LEU GLY LEU LEU GLY PRO LEU GLU ALA LEU GLY GLU SEQRES 9 A 289 ASP ALA VAL ALA SER VAL LEU ASP VAL ASN VAL VAL GLY SEQRES 10 A 289 THR VAL ARG MET LEU GLN ALA PHE LEU PRO ASP MET LYS SEQRES 11 A 289 ARG ARG GLY SER GLY ARG VAL LEU VAL THR GLY SER VAL SEQRES 12 A 289 GLY GLY LEU MET GLY LEU PRO PHE ASN ASP VAL TYR CYS SEQRES 13 A 289 ALA SER LYS PHE ALA LEU GLU GLY LEU CYS GLU SER LEU SEQRES 14 A 289 ALA VAL LEU LEU LEU PRO PHE GLY VAL HIS LEU SER LEU SEQRES 15 A 289 ILE GLU CYS GLY PRO VAL HIS THR ALA PHE MET GLU LYS SEQRES 16 A 289 VAL LEU GLY SER PRO GLU GLU VAL LEU ASP ARG THR ASP SEQRES 17 A 289 ILE HIS THR PHE HIS ARG PHE TYR GLN TYR LEU ALA HIS SEQRES 18 A 289 SER LYS GLN VAL PHE ARG GLU ALA ALA GLN ASN PRO GLU SEQRES 19 A 289 GLU VAL ALA GLU VAL PHE LEU THR ALA LEU ARG ALA PRO SEQRES 20 A 289 LYS PRO THR LEU ARG TYR PHE THR THR GLU ARG PHE LEU SEQRES 21 A 289 PRO LEU LEU ARG MET ARG LEU ASP ASP PRO SER GLY SER SEQRES 22 A 289 ASN TYR VAL THR ALA MET HIS ARG GLU VAL PHE GLY ASP SEQRES 23 A 289 VAL PRO ALA HET EST A 350 20 HET NAP A 360 48 HETNAM EST ESTRADIOL HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 2 EST C18 H24 O2 FORMUL 3 NAP C21 H28 N7 O17 P3 FORMUL 4 HOH *157(H2 O) HELIX 1 1 GLY A 13 ALA A 23 1 11 HELIX 2 2 LEU A 39 THR A 41 5 3 HELIX 3 3 GLY A 43 LEU A 52 1 10 HELIX 4 4 SER A 69 ARG A 78 1 10 HELIX 5 5 LEU A 99 ALA A 101 5 3 HELIX 6 6 GLU A 104 ASN A 114 1 11 HELIX 7 7 VAL A 116 ARG A 132 1 17 HELIX 8 8 VAL A 143 GLY A 145 5 3 HELIX 9 9 ASP A 153 PHE A 176 1 24 HELIX 10 10 MET A 193 LYS A 195 5 3 HELIX 11 11 PRO A 200 ARG A 206 1 7 HELIX 12 12 ILE A 209 ALA A 229 1 21 HELIX 13 13 PRO A 233 ARG A 245 1 13 HELIX 14 14 LEU A 260 ARG A 266 1 7 HELIX 15 15 SER A 273 VAL A 283 1 11 SHEET 1 A 7 ARG A 252 PHE A 254 0 SHEET 2 A 7 VAL A 178 CYS A 185 1 N LEU A 182 O TYR A 253 SHEET 3 A 7 GLY A 135 SER A 142 1 N GLY A 135 O HIS A 179 SHEET 4 A 7 VAL A 86 CYS A 89 1 N LEU A 87 O ARG A 136 SHEET 5 A 7 THR A 3 ILE A 7 1 N LEU A 6 O VAL A 86 SHEET 6 A 7 PHE A 30 LEU A 36 1 N LYS A 31 O THR A 3 SHEET 7 A 7 LEU A 59 GLN A 63 1 N GLU A 60 O VAL A 32 SITE 1 CAT 3 SER A 142 TYR A 155 LYS A 159 SITE 1 AC1 13 SER A 142 VAL A 143 GLY A 144 MET A 147 SITE 2 AC1 13 LEU A 149 TYR A 155 MET A 193 VAL A 225 SITE 3 AC1 13 PHE A 259 MET A 279 NAP A 360 HOH A 570 SITE 4 AC1 13 HOH A 628 SITE 1 AC2 34 GLY A 9 SER A 11 SER A 12 GLY A 13 SITE 2 AC2 34 ILE A 14 ARG A 37 LEU A 64 ASP A 65 SITE 3 AC2 34 VAL A 66 ARG A 67 ASN A 90 ALA A 91 SITE 4 AC2 34 GLY A 92 THR A 140 GLY A 141 SER A 142 SITE 5 AC2 34 TYR A 155 LYS A 159 CYS A 185 GLY A 186 SITE 6 AC2 34 PRO A 187 VAL A 188 THR A 190 PHE A 192 SITE 7 AC2 34 LYS A 195 EST A 350 HOH A 524 HOH A 525 SITE 8 AC2 34 HOH A 537 HOH A 550 HOH A 573 HOH A 603 SITE 9 AC2 34 HOH A 605 HOH A 618 CRYST1 111.380 48.540 60.770 90.00 115.13 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008978 0.000000 0.004211 0.00000 SCALE2 0.000000 0.020602 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018176 0.00000